DJIA 17,031.14 43.63 0.26%
NASDAQ 4,518.90 -48.70 -1.07%
S&P 500 1,984.13 -1.41 -0.07%
market minute promo

Allergan, Inc. (NYSE: AGN)

168.56 -0.69 (-0.41%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

AGN $168.56 -0.41%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $168.78
Previous Close $169.25
Daily Range $167.79 - $169.96
52-Week Range $87.88 - $174.49
Market Cap $50.1B
P/E Ratio 38.82
Dividend (Yield) $0.20 (0.1%)
Ex-Dividend Date
Dividend Pay Date
08/13/14
09/05/14
Volume 1,048,716
Average Daily Volume 2,037,207
Current FY EPS $5.79

Sector

Healthcare

Industry

Drugs

Allergan, Inc. (AGN) Description

A technology-driven, global health care company which discovers, develops and commercializes pharmaceutical and medical device products for markets such as ophthalmic, neurological, medical aesthetics, medical dermatological etc. Website: http://www.allergan.com/

News & Commentary Rss Feed

3 Questions for Allergan Inc.

Allergan is fighting tooth and nail to remain independent from Valeant Pharmaceuticals. Here are three questions investors should know the answers to heading into what is looking like the endgame.

NPS Pharmaceuticals' Natpara Gets Positive FDA Panel Vote - Analyst Blog

Alnylam Expands Pipeline with Preeclampsia Drug ALN-AGT - Analyst Blog

Pershing Square Submiterd Additional Special Meeting Requests On Friday, Total Submitted Represents

Pershing Square Submiterd Additional Special Meeting Requests On Friday, Total Submitted Represents 35.68% Of Allergan Shares

Sanofi Reports Data on Multiple Sclerosis Drug Lemtrada - Analyst Blog

Will Allergan's Board Be Revamped to Aid Valeant Buyout? - Analyst Blog

Eli Lilly/Boehringer's Insulin Biosimilar Gains EU Approval - Analyst Blog

Novartis Presents Data on Multiple Sclerosis Drug Gilenya - Analyst Blog

Allergan Comments On Pershing Square's Delivery Of Additional Requests From Stockholders Owning 1.5%

Allergan Comments On Pershing Square's Delivery Of Additional Requests From Stockholders Owning 1.5% Of Allergan's Shares

Auxilium Pharmaceuticals to Restructure, Cut Jobs by 30% - Analyst Blog

Emergent BioSolutions Wins $29M Anthrax Vaccine Deal - Analyst Blog

See More AGN News...

AGN's Top Competitors

AGN $168.56 (-0.41%)
Current stock: AGN
JNJ $104.72 (0.13%)
Current stock: JNJ
NVS $94.18 (0.45%)
Current stock: NVS
RHHBY $36.96 (0.71%)
Current stock: RHHBY